Michael Hayes
Overview
Explore the profile of Michael Hayes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
1301
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cruz Contreras Salas M, Berant D, Hayes M, Lin L, Cronin M, Gogarnoiu D, et al.
J Clin Orthod
. 2025 Mar;
59(1):48-59.
PMID: 40064337
No abstract available.
2.
Rudaks L, Stevanovski I, Yeow D, Reis A, Chintalaphani S, Cheong P, et al.
Ann Clin Transl Neurol
. 2025 Feb;
PMID: 40007153
Objective: The hereditary spastic-ataxia spectrum disorders are a group of disabling neurological diseases. The traditional genetic testing pathway is complex, multistep and leaves many cases unsolved. We aim to streamline...
3.
Bayati S, Nazeer J, Ng J, George A, Hayes M, Little M, et al.
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39400561
Objective: Identification of those at high and low risk of disease relapse is a major unmet need in the management of patients with ANCA-associated vasculitis (AAV). Precise stratification would allow...
4.
Henry T, Hayes M, Eisele C, Veldheer S, Allen S, Hoglen B, et al.
J Cancer Policy
. 2024 Oct;
42:100508.
PMID: 39357623
Background: The study aimed to gain insight into the experiences of patients with cancer and survivors regarding the integration of social needs assessment into their care, while also gathering perspectives...
5.
Fareed N, Olvera R, Wang Y, Hayes M, Larimore E, Balvanz P, et al.
JMIR Hum Factors
. 2024 Sep;
11():e51525.
PMID: 39250216
Background: Data dashboards are published tools that present visualizations; they are increasingly used to display data about behavioral health, social determinants of health, and chronic and infectious disease risks to...
6.
Wang J, Yen R, Beck A, Aggarwal P, Kong M, Hayes M, et al.
ACS Med Chem Lett
. 2024 Aug;
15(8):1396-1401.
PMID: 39140053
We introduce a new workflow that relies heavily on chemical quantitative structure-retention relationship (QSRR) models to accelerate method development for micro/mini-scale high-throughput purification (HTP). This provides faster access to new...
7.
Fellner A, Wali G, Mahant N, Grosz B, Ellis M, Narayanan R, et al.
Parkinsonism Relat Disord
. 2024 May;
124:107010.
PMID: 38772265
Purpose: We investigated the contribution of genomic data reanalysis to the diagnostic yield of dystonia patients who remained undiagnosed after prior genome sequencing. Methods: Probands with heterogeneous dystonia phenotypes who...
8.
El-Wahsh S, Fellner A, Hobbs M, Copty J, Deveson I, Stevanovski I, et al.
Mov Disord Clin Pract
. 2024 Mar;
11(5):582-585.
PMID: 38497520
No abstract available.
9.
Bergaoui K, Fraj M, Fragaszy S, Ghanim A, Hamadin O, Al-Karablieh E, et al.
Sci Rep
. 2024 Mar;
14(1):5414.
PMID: 38443431
This paper presents the composite drought indicator (CDI) that Jordanian, Lebanese, Moroccan, and Tunisian government agencies now produce monthly to support operational drought management decision making, and it describes their...
10.
Olsen A, Locascio J, Tuncali I, Laroussi N, Abatzis E, Kamenskaya P, et al.
Res Sq
. 2024 Jan;
PMID: 38196602
Background: Associations between phenotypic traits, environmental exposures, and Parkinson's disease have largely been evaluated one-by-one, piecemeal, and pre-selections. A comprehensive picture of comorbidities, phenotypes, exposures, and polypharmacy characterizing the complexity...